Amgen Canada has contracted with MDI Solutions to extend its initial engagement. MDI will be working with Amgen Canada to design and create additional patient modality-specific reports to support their clinical analysis for dialysis patients. MDI’s technical resources will again use their integration software, MD Link, to extract the HL7 data and upload it into the database for reporting. Amgen,, pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.